Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting

European Journal of Human Genetics

Volumn 24, Issue 12, 2016, Pages 1797-1802

  Christiansen, Sofie Lindgren ^a   Hertz, Christin Løth ^a   Ferrero Miliani, Laura ^a   Dahl, Morten ^b,d   Weeke, Peter Ejvin ^b   Lucamp, L ^c   Ottesen, Gyda Lolk ^a   Frank Hansen, Rune ^a   Bundgaard, Henning ^b   Morling, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c H LUNDBECK A S   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DNA; GENOMIC DNA; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CACNB2 GENE; CARDIAC CHANNELOPATHY; CARDIOMYOPATHY; CHILD; COHORT ANALYSIS; DENMARK; DSP GENE; DTNA GENE; FEMALE; FORENSIC GENETICS; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HUMAN TISSUE; KCNH2 GENE; KCNJ8 GENE; KCNQ1 GENE; LMNA GENE; MALE; MENTAL DISEASE; MIDDLE AGED; MISSENSE MUTATION; MYBPC3 GENE; NEXT GENERATION SEQUENCING; NONSENSE MUTATION; PHYSICAL ACTIVITY; PKP2 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; RYR2 GENE; SCN5A GENE; SUDDEN CARDIAC DEATH; TIME OF DEATH; TNNC1 GENE; TTN GENE; YOUNG ADULT; CHANNELOPATHY; GENE LOCUS; GENETICS; INFANT; MUTATION; PATHOLOGY; SUDDEN DEATH;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; CHANNELOPATHIES; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; FEMALE; FORENSIC GENETICS; GENETIC LOCI; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION;

EID: 84988568958     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2016.118     Document Type: Article

References (52)

1. Winkel BG, Holst AG, Theilade J et al: Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J 2011; 32: 983-990.
2. Risgaard B, Winkel BG, Jabbari R et al: Burden of sudden cardiac death in persons aged 1 to 49 years: nationwide study in Denmark. Circ Arrhythm Electrophysiol 2014; 7: 205-211.
3. Cerrone M, Lin X, Zhang M et al: Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation 2014; 129: 1092-1103.
4. Zhang M, Tavora F, Oliveira JB et al: PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA). Circ J 2012; 76: 189-194.
5. Zhang Q, Deng C, Rao F et al: Silencing of desmoplakin decreases connexin43/Nav1.5 expression and sodium current in HL1 cardiomyocytes. Mol Med Rep 2013; 8: 780-786.
6. Rizzo S, Lodder EM, Verkerk AO et al: Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res 2012; 95: 409-418.
7. Skinner JR, Crawford J, Smith W et al: Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm 2011; 8: 412-419.
8. Winkel BG, Larsen MK, Berge KE et al: The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases. J Cardiovasc Electrophysiol 2012; 23: 1092-1098.
9. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ: Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc2012; 87: 524-539.
10. Kauferstein S, Kiehne N, Jenewein T et al: Genetic analysis of sudden unexplained death: a multidisciplinary approach. Forensic Sci Int 2013; 229: 122-127.
11. Hertz CL, Christiansen SL, Ferrero-Miliani L et al: Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases. Int J Legal Med 2015; 129: 793-800.
12. Narula N, Tester DJ, Paulmichl A, Maleszewski JJ, Ackerman MJ: Post-mortem Whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: a case series. Pediatr Cardiol 2015; 36: 768-778.
13. Bagnall RD, Das KJ, Duflou J, Semsarian C: Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. Heart Rhythm 2014; 11: 655-662.
14. Loporcaro CG, Tester DJ, Maleszewski JJ, Kruisselbrink T, Ackerman MJ: Confirmation of cause and manner of death via a comprehensive cardiac autopsy including whole exome next-generation sequencing. Arch Pathol Lab Med2014; 138: 1083-1089.
15. Hertz CL, Christiansen SL, Ferrero-Miliani L et al: Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart. Int J Legal Med 2015; 130: 91-102.
16. Hertz CL, Christiansen SL, Larsen MK et al: Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases. Eur J Hum Genet 2015; 24: 817-822.
17. Stenson PD, Ball EV, Mort M et al: Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003; 21: 577-581.
18. Richards S, Aziz N, Bale S et al: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-423.
19. Ng D, Johnston JJ, Teer JK et al: Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet 2013; 6: 337-346.
20. Dorschner MO, Amendola LM, Turner EH et al: Actionable, pathogenic incidental findings in 1000 participants' exomes. Am J Hum Genet 2013; 93: 631-640.
21. Mathieson I, McVean G: Differential confounding of rare and common variants in spatially structured populations. Nat Genet 2012; 44: 243-246.
22. Lohmueller KE, Sparso T, Li Q et al: Whole-exome sequencing of 2000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am J Hum Genet 2013; 93: 1072-1086.
23. R Core Team. R: A language and environment for statistical computing, 2014.
24. Gerull B, Heuser A, Wichter T et al: Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004; 36: 1162-1164.
25. Christensen AH, Benn M, Tybjaerg-Hansen A, Haunso S, Svendsen JH: Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients- disease-causing or innocent bystanders? Cardiology 2010; 115: 148-154.
26. Brion M, Allegue C, Santori M et al: Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Sci Int 2012; 219: 278-281.
27. Zimmerman RS, Cox S, Lakdawala NK et al: A novel custom resequencing array for dilated cardiomyopathy. Genet Med 2010; 12: 268-278.
28. Morita H, Rehm HL, Menesses A et al: Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 2008; 358: 1899-1908.
29. Andreasen C, Nielsen JB, Refsgaard L et al: New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet 2013; 21: 918-928.
30. Roberts JD, Veinot JP, Rutberg J, Gollob MH: Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol 2010; 19: 316-320.
31. Laursen TM, Nordentoft M, Mortensen PB: Excess early mortality in schizophrenia. Annu Rev Clin Psychol 2014; 10: 425-448.
32. Sweeting J, Duflou J, Semsarian C: Postmortem analysis of cardiovascular deaths in schizophrenia: a 10-year review. Schizophr Res 2013; 150: 398-403.
33. Weeke P, Jensen A, Folke F et al: Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 2012; 92: 72-79.
34. Fanoe S, Kristensen D, Fink-Jensen A et al: Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J 2014; 35: 1306-1315.
35. Straus SM, Bleumink GS, Dieleman JP et al: Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164: 1293-1297.
36. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT: Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161-1167.
37. Ray WA, Chung CP, Murray KT, Hall K, Stein CM: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360: 225-235.
38. Nashef L: Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997; 38(Suppl 11): S6-S8.
39. Holst AG, Winkel BG, Risgaard B et al: Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study. Epilepsia 2013; 54: 1613-1620.
40. Partemi S, Vidal MC, Striano P et al: Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series. Int J Legal Med 2015; 129: 495-504.
41. Verma A, Kumar A: Sudden unexpected death in epilepsy: some approaches for its prevention and medico-legal consideration. Acta Neurol Belg 2015; 115: 207-212.
42. Bermeo-Ovalle AC, Kennedy JD, Schuele SU: Cardiac and Autonomic Mechanisms Contributing to SUDEP. J Clin Neurophysiol 2015; 32: 21-29.
43. Tu E, Bagnall RD, Duflou J, Semsarian C: Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. Brain Pathol 2011; 21: 201-208.
44. Ponting CP: Novel repeats in ryanodine and IP3 receptors and protein O-mannosyltransferases. Trends Biochem Sci 2000; 25: 48-50.
45. Burashnikov E, Pfeiffer R, Barajas-Martinez H et al: Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 2010; 7: 1872-1882.
46. Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L: Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999; 34: 823-829.
47. Van Driest SL, Vasile VC, Ommen SR et al: Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44: 1903-1910.
48. Tester DJ, Will ML, Haglund CM, Ackerman MJ: Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 507-517.
49. Zareba W, Moss AJ, Sheu G et al: Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol 2003; 14: 1149-1153.
50. van Tintelen JP, Entius MM, Bhuiyan ZA et al: Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006; 113: 1650-1658.
51. Shy D, Gillet L, Ogrodnik J et al: PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function. Circulation 2014; 130: 147-160.
52. Kapplinger JD, Tester DJ, Salisbury BA et al: Spectrum and prevalence of mutations from the first 2500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009; 6: 1297-1303.